Associated tags: Personalized medicine, Medicine, Drug development, Pharmaceutical industry, Senior, PMG, Precision, Science, University, Nursing, Pfizer, PRA Health Sciences
Locations: MARYLAND, MASSACHUSETTS, LONZA, NORTH AMERICA, EUROPE
Retrieved on:
Thursday, December 14, 2023
Social,
Annual report,
Personalized medicine,
GHG,
Patient,
General counsel,
Erg,
PMG,
Employee resource group,
Drug development,
Greenhouse gas,
ESG,
Management,
Pharmaceutical industry BETHESDA, Md., Dec. 14, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, has published its 2023 Environmental, Social and Governance (ESG) Report.
Key Points:
- BETHESDA, Md., Dec. 14, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, has published its 2023 Environmental, Social and Governance (ESG) Report.
- This inaugural annual report provides a detailed account of the organization's priorities, which include a focus on doing better for people within the PMG organization and the broader community, including environmental preservation, social well-being and ethical leadership.
- "At PMG, our mission is to accelerate development and access to breakthrough therapies that improve the lives of patients in need," said Stacey Hanna, General Counsel and Chief Compliance Officer of Precision Medicine Group.
- In 2023, PMG initiated various energy efficiency projects and standards across the company's facilities and measured associated emissions reductions from the baseline.
Retrieved on:
Wednesday, April 26, 2023
PMG,
Psychology,
Human resources,
Industrial and organizational psychology,
Drug development,
University,
Senior,
General counsel,
IQVIA,
Culture,
Abbott,
Springfield College,
Personalized medicine,
Cornell Law School,
Risk management,
Record,
KKR,
Precision,
Hamilton College,
Millennium,
PRA Health Sciences,
Patient,
Ethics,
Growth,
University of Wisconsin–Stevens Point,
Pfizer,
Nursing,
Management BETHESDA, Md., April 26, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointments of Stacey Hanna, General Counsel and Chief Compliance Officer, and Tina Durocher-Murphy, Chief People Officer. In these roles, Stacey and Tina are responsible for all legal and compliance and human resources functions, respectively, across the enterprise. Both leaders will report directly to Mark Clein, Chief Executive Officer of Precision Medicine Group.
Key Points:
- Stacey Hanna, General Counsel and Chief Compliance Officer, leads all legal and compliance functions across Precision Medicine Group
Tina Durocher-Murphy, Chief People Officer, is charged with fostering a culture committed to growth, teamwork, professional development, and improving patient lives
BETHESDA, Md., April 26, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointments of Stacey Hanna, General Counsel and Chief Compliance Officer, and Tina Durocher-Murphy, Chief People Officer.
- Both leaders will report directly to Mark Clein, Chief Executive Officer of Precision Medicine Group.
- "As Precision Medicine Group innovates and evolves, adding senior-level talent like Tina and Stacey contributes significantly to scaling people, process, and culture for our next phase of growth," said Clein.
- Prior to joining PMG, Stacey was the Vice President and General Counsel, Global Ethics & Compliance at Lonza.
PMG,
Strategic planning,
Science 37,
Toxicology and Applied Pharmacology,
Doctor of Philosophy,
Senior,
Translation,
Pharmacology,
American College of Clinical Pharmacology,
Science,
Diplomate of National Board,
Enterprise,
American College,
Personalized medicine,
Development,
Drug development,
ChromeOS,
ICON,
DevOps,
ICON PLC,
Pfizer,
Management,
Nursing BETHESDA, Md., March 13, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointment of John Hubbard, PhD, as Chairman of its Board of Directors.
Key Points:
- BETHESDA, Md., March 13, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointment of John Hubbard, PhD, as Chairman of its Board of Directors.
- "We are thrilled to welcome John to our Board.
- He is a highly regarded leader in the pharmaceutical industry with extensive experience in clinical development and operations, strategic planning and business development," said Mark Clein, Chief Executive Officer of Precision Medicine Group.
- Earlier, he was Group President of ICON plc's Global Clinical Research Services Division, one of the top five global CROs.
Retrieved on:
Thursday, January 26, 2023
Southern Illinois University,
University,
Personalized medicine,
Master of Health Administration,
Fulling,
PVH,
Precision,
Tulane University,
PRA Health Sciences,
Bachelor of Science,
Growth,
Organization,
Doug Perlman,
Creativity,
PRA,
Senior,
Management,
Symphony,
Science BETHESDA, Md., Jan. 26, 2023 /PRNewswire/ -- Precision Value & Health (PVH), today announces that Doug Fulling has joined as President. As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Doug will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.
Key Points:
- BETHESDA, Md., Jan. 26, 2023 /PRNewswire/ -- Precision Value & Health (PVH) , today announces that Doug Fulling has joined as President.
- Mark Clein, Precision Medicine Group's CEO, said, "We are thrilled to have Doug join our team.
- Before joining Precision, Fulling served as President of Symphony Health where they reengineered a $250M data and analytics business to achieve double digit, top and bottom-line growth in less than three years.
- Fulling earned his Bachelor of Science from Southern Illinois University and Master of Health Administration from Tulane University.
